Similarly, previous studies found that younger symptomatic AD onset is associated with stronger fronto-parietal gray-matter atrophy5, hypoperfusion and glucose hypometabolism45,46, which have been shown to be closely associated with tau pathology in AD13. This evidence concerns the gene MAPT and Alzheimer disease.